EVANSVILLE, Ind. (WEHT) – U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19.
The Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.
Eyewitness News Brandon Bartlett talked to a local doctor that was a part of the process.
(This story was originally published on November 10, 2020)